Rapid Diagnosis of Sepsis

Gerald J Kost, Nam Tran, Richard F. Louie, Zuping Tang, Ashley A. Woodruff, Timothy E Albertson, Robert W. Derlet, Rahman Azari

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Unacceptable mortality rates and excessively high costs of sepsis can be attributed in part to delayed pathogen identification, poorly focused treatment, and unjustified antimicrobial use. Rapid diagnosis of pathogens, immediately focused antibiotics, and quick interruption of dysfunctional sepsis cascades could optimize clinical value. Value analysis constructs evidence-based hypotheses, called value propositions, that form a value model for the use of rapid diagnosis and point-of-care testing (POCT) in sepsis. Rapid diagnostic methods, such as nucleic acid testing (NAT), can assure fast therapeutic turnaround time. The authors applied NAT hypothetically to different scenarios for which they performed value analysis of patient and hospital costs and of medical outcomes. Value propositions were constructed for both adult and pediatric clinical situations. The authors conclude that rapid diagnosis by NAT can reduce the probability of complications, allow physicians to immediately focus treatment, and decrease both costs and mortality. Expected benefits for both pediatric and adult patients validate the need for continued NAT research and development of POCT for critically ill patients with sepsis.

Original languageEnglish (US)
Pages (from-to)163-171
Number of pages9
JournalPlastic Surgical Nursing
Volume2
Issue number3
StatePublished - 2003

Fingerprint

Nucleic Acids
Sepsis
Pediatrics
Costs and Cost Analysis
Mortality
Hospital Costs
Critical Illness
Therapeutics
Anti-Bacterial Agents
Physicians
Research
Point-of-Care Testing

Keywords

  • activated protein C
  • microbial resistance
  • multiple organ dysfunction syndrome
  • polymerase chain reaction
  • sepsis
  • therapeutic turnaround time

ASJC Scopus subject areas

  • Surgery
  • Medical–Surgical
  • Advanced and Specialized Nursing

Cite this

Kost, G. J., Tran, N., Louie, R. F., Tang, Z., Woodruff, A. A., Albertson, T. E., ... Azari, R. (2003). Rapid Diagnosis of Sepsis. Plastic Surgical Nursing, 2(3), 163-171.

Rapid Diagnosis of Sepsis. / Kost, Gerald J; Tran, Nam; Louie, Richard F.; Tang, Zuping; Woodruff, Ashley A.; Albertson, Timothy E; Derlet, Robert W.; Azari, Rahman.

In: Plastic Surgical Nursing, Vol. 2, No. 3, 2003, p. 163-171.

Research output: Contribution to journalArticle

Kost, GJ, Tran, N, Louie, RF, Tang, Z, Woodruff, AA, Albertson, TE, Derlet, RW & Azari, R 2003, 'Rapid Diagnosis of Sepsis', Plastic Surgical Nursing, vol. 2, no. 3, pp. 163-171.
Kost GJ, Tran N, Louie RF, Tang Z, Woodruff AA, Albertson TE et al. Rapid Diagnosis of Sepsis. Plastic Surgical Nursing. 2003;2(3):163-171.
Kost, Gerald J ; Tran, Nam ; Louie, Richard F. ; Tang, Zuping ; Woodruff, Ashley A. ; Albertson, Timothy E ; Derlet, Robert W. ; Azari, Rahman. / Rapid Diagnosis of Sepsis. In: Plastic Surgical Nursing. 2003 ; Vol. 2, No. 3. pp. 163-171.
@article{845d5f17bf4644f8b58604c3be5aed72,
title = "Rapid Diagnosis of Sepsis",
abstract = "Unacceptable mortality rates and excessively high costs of sepsis can be attributed in part to delayed pathogen identification, poorly focused treatment, and unjustified antimicrobial use. Rapid diagnosis of pathogens, immediately focused antibiotics, and quick interruption of dysfunctional sepsis cascades could optimize clinical value. Value analysis constructs evidence-based hypotheses, called value propositions, that form a value model for the use of rapid diagnosis and point-of-care testing (POCT) in sepsis. Rapid diagnostic methods, such as nucleic acid testing (NAT), can assure fast therapeutic turnaround time. The authors applied NAT hypothetically to different scenarios for which they performed value analysis of patient and hospital costs and of medical outcomes. Value propositions were constructed for both adult and pediatric clinical situations. The authors conclude that rapid diagnosis by NAT can reduce the probability of complications, allow physicians to immediately focus treatment, and decrease both costs and mortality. Expected benefits for both pediatric and adult patients validate the need for continued NAT research and development of POCT for critically ill patients with sepsis.",
keywords = "activated protein C, microbial resistance, multiple organ dysfunction syndrome, polymerase chain reaction, sepsis, therapeutic turnaround time",
author = "Kost, {Gerald J} and Nam Tran and Louie, {Richard F.} and Zuping Tang and Woodruff, {Ashley A.} and Albertson, {Timothy E} and Derlet, {Robert W.} and Rahman Azari",
year = "2003",
language = "English (US)",
volume = "2",
pages = "163--171",
journal = "Plastic Surgical Nursing",
issn = "0741-5206",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Rapid Diagnosis of Sepsis

AU - Kost, Gerald J

AU - Tran, Nam

AU - Louie, Richard F.

AU - Tang, Zuping

AU - Woodruff, Ashley A.

AU - Albertson, Timothy E

AU - Derlet, Robert W.

AU - Azari, Rahman

PY - 2003

Y1 - 2003

N2 - Unacceptable mortality rates and excessively high costs of sepsis can be attributed in part to delayed pathogen identification, poorly focused treatment, and unjustified antimicrobial use. Rapid diagnosis of pathogens, immediately focused antibiotics, and quick interruption of dysfunctional sepsis cascades could optimize clinical value. Value analysis constructs evidence-based hypotheses, called value propositions, that form a value model for the use of rapid diagnosis and point-of-care testing (POCT) in sepsis. Rapid diagnostic methods, such as nucleic acid testing (NAT), can assure fast therapeutic turnaround time. The authors applied NAT hypothetically to different scenarios for which they performed value analysis of patient and hospital costs and of medical outcomes. Value propositions were constructed for both adult and pediatric clinical situations. The authors conclude that rapid diagnosis by NAT can reduce the probability of complications, allow physicians to immediately focus treatment, and decrease both costs and mortality. Expected benefits for both pediatric and adult patients validate the need for continued NAT research and development of POCT for critically ill patients with sepsis.

AB - Unacceptable mortality rates and excessively high costs of sepsis can be attributed in part to delayed pathogen identification, poorly focused treatment, and unjustified antimicrobial use. Rapid diagnosis of pathogens, immediately focused antibiotics, and quick interruption of dysfunctional sepsis cascades could optimize clinical value. Value analysis constructs evidence-based hypotheses, called value propositions, that form a value model for the use of rapid diagnosis and point-of-care testing (POCT) in sepsis. Rapid diagnostic methods, such as nucleic acid testing (NAT), can assure fast therapeutic turnaround time. The authors applied NAT hypothetically to different scenarios for which they performed value analysis of patient and hospital costs and of medical outcomes. Value propositions were constructed for both adult and pediatric clinical situations. The authors conclude that rapid diagnosis by NAT can reduce the probability of complications, allow physicians to immediately focus treatment, and decrease both costs and mortality. Expected benefits for both pediatric and adult patients validate the need for continued NAT research and development of POCT for critically ill patients with sepsis.

KW - activated protein C

KW - microbial resistance

KW - multiple organ dysfunction syndrome

KW - polymerase chain reaction

KW - sepsis

KW - therapeutic turnaround time

UR - http://www.scopus.com/inward/record.url?scp=85026180829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026180829&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85026180829

VL - 2

SP - 163

EP - 171

JO - Plastic Surgical Nursing

JF - Plastic Surgical Nursing

SN - 0741-5206

IS - 3

ER -